Trial intelligence / Profile preview

Steroid-free Immunosuppressant Regimen in Pediatric Liver Transplantation

NCT00694408Phase 3Terminated

Sponsor
Birmingham Women's and Children's NHS Foundation Trust
Start
Jun 2008
Primary completion
Aug 2011
Modality
Monoclonal Antibodies
Countries
1
01

Overview

A Phase 3 trial of daclizumab in liver transplantation, sponsored by Birmingham Women's and Children's NHS Foundation Trust. Started Jun 2008; status: terminated.

02

Drugs

daclizumab
03

Conditions

liver transplantation

Beyond the preview

Go deeper on NCT00694408.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00694408.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call